RxDoctor Payments Data

Julie Ashcraft

Psychiatric/Mental Health · Pueblo, CONPI 1366045650

Payments from drug & device makers

$530in general payments, 2019–2025

Across 40 payments — averaging $13.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sunovion Pharmaceuticals Inc.$126
  • Neurocrine Biosciences, Inc.$113
  • Takeda Pharmaceuticals U.S.A., Inc.$66
  • AbbVie$49
  • Vanda Pharmaceuticals Inc.$42
  • Acadia Pharmaceuticals Inc$42
  • plus $92 from 6 others

What the payments were for

  • Food & beverage$530100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$530 in reported general payments places this provider in the 60th percentile of 873 psychiatric/mental health providers in Colorado.

See all psychiatric/mental health providers in Colorado

Medicare billing

Part B allowed, 2024
$4,338
Medicare patients
11
Services billed
54

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate11$100,538
TrintellixVortioxetine Hydrobromide21$18,172
Hydroxyzine Hcl23$1,294
Vilazodone Hcl12$1,139
Oxcarbazepine15$717
Buspirone Hcl21$537
Aripiprazole32$418
Bupropion XlBupropion Hcl14$280
Escitalopram Oxalate26$216
Methylphenidate Hcl12$178
Lamotrigine16$173
Propranolol Hcl17$116
Trazodone Hcl28$99
Gabapentin13$84
Fluoxetine Hcl25$84

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$113$100,53811 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$66$18,17221 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 873 psychiatric/mental health providers in Colorado.

Other psychiatric/mental health in Pueblo

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →